Pokarna Ltd. Change in Estimates:

Size: px
Start display at page:

Download "Pokarna Ltd. Change in Estimates:"

Transcription

1 Pokarna Ltd. Absolute : LONG Relative : Overweight 3QFY16 Result : Estimate ( ), TP ( ), Rating ( ) Regular Coverage 57% ATR in 14 Months Stellar performance continues; Retain LONG as valuations are mouthwatering Building Material 2016 Equirus All rights reserved Rating Information Price (Rs) 749 Target Price (Rs) 1,242 Target Date Target Set On Implied yrs of growth (DCF) st Mar'17 Fair Value (DCF) 1,229 Fair Value (DDM) 157 Ind Benchmark Model Portfolio Position Stock Information 12th Feb'16 SPBSSIP LONG Market Cap (Rs Mn) 4,646 Free Float (%) % 52 Wk H/L (Rs) 1425/586 Avg Daily Volume (1yr) 15,060 Avg Daily Value (Rs Mn) 14 Equity Cap (Rs Mn) 62 Face Value (Rs) 10 Bloomberg Code POKR IN Ownership Recent 3M 12M Promoters 72.3 % 0.0 % -2.8 % DII 6.9 % -0.1 % 5.7 % FII 1.0 % 0.2 % -1.8 % Public 19.9 % 0.1 % -1.2 % Price % 1M 3M 12M Absolute % % -1.3 % Vs Industry -0.7 % % 13.5 % Vs Aro Granite % % % Vs Asian Granito % % -3.8 % Consolidated Quarterly EPS forecast Rs/Share 1Q 2Q 3Q 4Q EPS (15A) EPS (16E) Pokarna once again delivered excellent quarter led by strong subsidiary performance (PESL- Quartz business). Consolidated Sales/EBITDA/PAT grew by 24%/61%/202% yoy, 6%/39%/113% ahead of Equirus estimates (EE). Pokarna s quartz subsidiary (PESL) posted robust growth of 62%/10% yoy/qoq. We are seeing tremendous demand improvement in US quartz market as Caesarstone s (leader with ~20% market share) sales also grew ~20% yoy in CY15. PESL is shifting its focus from bread & butter products to value added products, which has started yielding results in form of alltime high EBITDAM. We expect Pokarna to sustain this growth momentum & robust profitability going forward & revise our FY16E/FY17E EPS estimates by 27%/13% respectively. We maintain LONG rating with a Mar 17 TP of Rs. 1,242 at 10x TTM EPS Yet another blockbuster performance led by PESL: Consolidated sales grew 24% yoy, 6% higher than EE due to 62%/10% yoy/qoq growth in quartz business. It reported all time high consolidated EBITDAM at 39%, (improved by 885bps/683bps yoy/qoq), and 903bps ahead of EE. Quartz business margins improved to 49.5% (2000bps/1420bps yoy/qoq) due to, 1) revenue mix shifting to higher margin products like jumbo quartz slabs, 2) benefits of favourable negotiations with raw material suppliers, 3) better capacity utilization, and 4) USD-INR appreciation of 6%/2% yoy/qoq. US quartz market showing tremendous growth potential: US continue to be PESL s largest market (with ~75% revenue contribution). It continues to hold large potential for growth (~20%+ CAGR) as quartz material conversion continues to be powerful (with ~10% quartz penetration at present) & new housing market in US expect to grow at ~18% in CY14-16E (as per housing economics study). PESL continues to focus on strengthening its brand through R&D investment & development of new colors, designs, and textures to tap this growth potential. Granite realizations remained under pressure due to increased competitive environment: Pokarna s granite revenue growth remained subdued over last 2 quarters on the back of decline in realizations of granite products. Company is facing stiff pricing competition from Brazilian (Largest granite producer) players primarily due to more depreciation of Brazilian real (~51%) than INR (6%) vs. USD. Retain LONG as valuations are mouthwatering: We believe Pokarna is major beneficiary of rapidly expanding quartz countertop market, is well positioned to post consolidated Sales/EBITDA/PAT CAGR of 19%/20%/24%. At CMP of Rs. 750, stock is trading at 7.5x FY16E TTM EPS, implying mouthwatering valuations. Hence, we reiterate LONG rating with Mar 17 TP of Rs 1,242 at 10x TTM EPS. (vs. earlier Dec 16 TP of Rs at 13x) Change in Estimates: Rs. Mn FY16E Chg (%) FY17E Chg (%) Sales 3,977-1% 4,575-7% EBITDA 1,328 10% 1,559 6% PAT % % EPS % % Consolidated Financials Rs. Mn YE Mar FY15A FY16E FY17E FY18E Sales 3,264 3,977 4,575 5,630 EBITDA 836 1,328 1,559 1,919 Depreciation Interest Expense Other Income Reported PAT Recurring PAT Total Equity 530 1,114 1,825 2,692 Gross Debt 2,598 2,380 2,834 2,909 Cash Rs Per Share FY15A FY16E FY17E FY18E Earnings Book Value Dividends FCFF P/E (x) P/B (x) EV/EBITDA (x) ROE (%) 60 % 75 % 52 % 42 % Core ROIC (%) 12 % 25 % 24 % 23 % EBITDA Margin (%) 26 % 33 % 34 % 34 % Net Margin (%) 7 % 16 % 17 % 17 % February 14, 2016 Analysts: Umesh Raut umesh.raut@equirus.com ( ) Page 1 of 10 Before reading this report, you must refer to the disclaimer on the last page.

2 Exhibit-01: Granite Revenue & EBITM trend Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 Granite revenue (Rs mn) Granite EBITM (%) 35% 30% 25% 20% 15% Source: Company, Equirus Securities Exhibit-02: Quartz Revenue & EBITM trend Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 Quartz revenue (Rs mn) Quartz EBITM (%) 55% 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% Source: Company, Equirus Securities February 14, 2016 Analysts: Umesh Raut ( ) Page 2 of 10

3 Quarterly Result Table (Consolidated) % Change Q3FY16 Q3FY16E Q2FY16 Q3FY15 Q3FY16E Q2FY16 Q3FY15 Net Sales % -1% 24% Comments Raw Materials % -21% -1% Employee Cost % 3% 31% Other Expenses % -8% 9% Total Expenditures % -11% 8% EBITDA % 20% 61% Depreciation % 6% -3% EBIT % 22% 77% Interest % -15% -6% Other Income % 77% 29% PBT % 46% 137% Tax % 13% 34% PAT before MI & Associates % 60% 202% Minority Interest Profit from Assoc Recurring PAT % 60% 202% Extraordinaries Reported PAT % 60% 41% EPS (Rs) % 60% 202% EBITDA Margin 39% 30% 32% 30% 903 bps 683 bps 885 bps EBIT Margin 34% 23% 27% 24% 1078 bps 649 bps 1020 bps PBT Margin 27% 15% 18% 14% 1264 bps 893 bps 1307 bps PAT Margin 21% 11% 13% 19% 1070 bps 818 bps 254 bps Tax Rate 22% 27% 28% 39% -555 bps -644 bps bps February 14, 2016 Analysts: Umesh Raut umesh.raut@equirus.com ( ) Page 3 of 10

4 Company Snapshot How we differ from Consensus EPS Sales PAT - Equirus Consensus % Diff Comment FY16E FY17E FY16E 3, FY17E 4, FY16E FY17E Our Key Investment arguments: A fully integrated business model in granite segment will facilitate a steady revenue growth: Ease of raw material availability from its own mines, state-of-the-art processing facilities along with a robust distribution network in more than 49 countries will aid volume improvement. Well positioned to capture the fast growing Quartz demand in US markets: Exclusive licensee of patented Breton Stone technology to manufacture high grade export quality quartz, distribution in more than 20 countries, increasing presence in higher value quartz and higher sales of quartz under its own brand Quantra will help Pokarna to see 20% revenue CAGR over FY16E-18E. Key Estimates: (Rs. mn) FY14 FY15 FY16E FY17E FY18E Granite Revenues 1,561 1,906 1,928 2,050 2,358 Quartz Revenues 624 1,357 2,049 2,524 3,272 Net sales EBITDA EBITDA Margin (%) 20% 26% 33% 34% 34% PAT (without e/o items) Risk to Our View: Delay in capacity expansion Key Triggers: Pick up in quartz business, revival in granite volumes and improvement in margins due to improved utilization in quartz business and backward integration in granite business Sensitivity to Key Variables % Change % Impact on EPS EBITDAM -1 % -5 % DCF Valuations & Assumptions Rf Beta Ke Term. Growth Debt/IC in Term. Yr 7.5 % % 3.0 % 52.0 % - FY16E FY17E FY18-20E FY21-25E FY26-30E Sales Growth 22 % 15 % 19 % 10 % 7 % NOPAT Margin 21 % 22 % 20 % 19 % 19 % IC Turnover RoIC 24.9 % 24.4 % 21.1 % 19.4 % 19.1 % Years of strong growth Valuation as on date (Rs) ,033 1,100 Valuation as of Mar' ,155 1,229 Based on DCF, assuming 15 years of 12% CAGR growth and 21% average ROIC, we derive current fair value of Rs. 1,100 and 31 st Mar 17 fair value of Rs. 1,229. Company Description: Pokarna Ltd., promoted by Mr. Gautam Chand Jain, is one of the leading exporters of Granite from India. It is the only granite company in India to be fully integrated from quarries to marketing. It exports granite to over 49 countries around the world. The company through its wholly owned subsidiary M/s Pokarna Engineered Stone Ltd. manufactures Natural Quartz Surfaces also known as Engineered Stone or Compound Stone. It is the only licensee of Breton Stone Technology in India for Quartz surfaces. It exports quartz surfaces to more than 20 countries. Comparable valuation EPS P/E BPS P/B RoE Div Yield Mkt Cap Price Target Company Reco. CMP Rs. Mn. Target Date FY14A FY16E FY17E FY14A FY16E FY17E FY14A FY16E FY14A FY16E FY17E FY14A FY16E Pokarna LONG 749 4,646 1,242 Mar' % 75 % 52 % 0.4 % 0.6 % Aro Granite NR NR NR % % - Asian Granito NR 117 2,632 NR NR % % - February 14, 2016 Analysts: Umesh Raut umesh.raut@equirus.com ( ) Page 4 of 10

5 Consolidated Quarterly Earnings Forecast and Key Drivers Rs in Mn 1Q15A 2Q15A 3Q15A 4Q15A 1Q16A 2Q16A 3Q16A 4Q16E 1Q17E 2Q17E 3Q17E 4Q17E FY15A FY16E FY17E FY18E Revenue , ,055 1,068 1,144 1,118 1,245 3,264 3,977 4,575 5,630 Raw Materials ,124 1,424 Employee Cost Other Expenses ,199 1,361 1,476 1,813 User Defined Common Expense User Defined Common Expense EBITDA ,328 1,559 1,919 Depreciation EBIT ,133 1,337 1,659 Interest Other Income PBT ,018 1,304 Tax PAT bef. MI & Assoc Minority Interest Profit from Assoc Recurring PAT Extraordinaries Reported PAT EPS (Rs) Key Drivers Granite revenue (Rs mn) ,906 1,928 2,050 2,358 Quartz revenue (Rs mn) ,357 2,049 2,524 3, Sequential Growth (%) Revenue -8 % 34 % -5 % 32 % -7 % 2 % -1 % 9 % 1 % 7 % -2 % 11 % Raw Materials -14 % 53 % -22 % 44 % -18 % 6 % -21 % 14 % 19 % 3 % 1 % 12 % EBITDA 2 % 48 % 23 % 20 % 2 % 9 % 20 % -8 % -2 % 18 % -1 % 4 % EBIT -19 % 113 % 43 % 23 % 6 % 11 % 22 % -12 % 0 % 21 % -1 % 4 % Recurring PAT -110 % -485 % 79 % 100 % -14 % 11 % 60 % -23 % 0 % 27 % -4 % 4 % EPS -110 % -485 % 79 % 100 % -14 % 11 % 60 % -23 % 0 % 27 % -4 % 4 % Yearly Growth (%) Revenue % 54 % 56 % 19 % 24 % 2 % 11 % 16 % 15 % 18 % 42 % 22 % 15 % 23 % EBITDA % 124 % 123 % 65 % 61 % 24 % 18 % 28 % 6 % 20 % 80 % 59 % 17 % 23 % EBIT % 205 % 300 % 108 % 77 % 26 % 18 % 29 % 4 % 23 % 133 % 87 % 18 % 24 % Recurring PAT - - 1,156 % 34 % -1,280 % 239 % 202 % 17 % 37 % 57 % -5 % 27 % 457 % 163 % 25 % 24 % EPS - - 1,156 % 34 % -1,280 % 239 % 202 % 17 % 37 % 57 % -5 % 27 % 457 % 163 % 25 % 24 % Margin (%) EBITDA 21 % 23 % 30 % 27 % 30 % 32 % 39 % 33 % 32 % 35 % 36 % 34 % 26 % 33 % 34 % 34 % EBIT 10 % 16 % 24 % 22 % 25 % 27 % 34 % 27 % 27 % 30 % 31 % 29 % 19 % 28 % 29 % 29 % PBT -1 % 7 % 14 % 18 % 17 % 18 % 27 % 20 % 20 % 24 % 23 % 22 % 11 % 21 % 22 % 23 % PAT -2 % 5 % 9 % 13 % 12 % 13 % 21 % 15 % 15 % 18 % 18 % 17 % 7 % 16 % 17 % 17 % February 14, 2016 Analysts: Umesh Raut umesh.raut@equirus.com ( ) Page 5 of 10

6 Mar/14 Jun/14 Sep/14 Dec/14 Mar/15 Jun/15 Sep/15 Dec/15 Mar/16 Jun/16 Sep/16 Dec/16 Mar/09 Jun/09 Sep/09 Dec/09 Mar/10 Jun/10 Sep/10 Dec/10 Mar/11 Jun/11 Sep/11 Dec/11 Mar/12 Jun/12 Sep/12 Dec/12 Mar/13 Jun/13 Sep/13 Dec/13 Mar/14 Jun/14 Sep/14 Dec/14 Mar/15 Jun/15 Sep/15 Dec/15 Mar/16 Jun/16 Sep/16 Dec/16 Mar/12 Jun/12 Sep/12 Dec/12 Mar/13 Jun/13 Sep/13 Dec/13 Mar/14 Jun/14 Sep/14 Dec/14 Mar/15 Jun/15 Sep/15 Dec/15 Mar/16 Jun/16 Sep/16 Dec/16 Consolidated Financials Pokarna Ltd Absolute LONG Relative Overweight 57% ATR in 14 Months P&L (Rs Mn) FY15A FY16E FY17E FY18E Balance Sheet (Rs Mn) FY15A FY16E FY17E FY18E Cash Flow (Rs Mn) FY15A FY16E FY17E FY18E Revenue 3,264 3,977 4,575 5,630 Equity Capital PBT ,018 1,304 Op. Expenditure 2,428 2,649 3,016 3,710 Reserve 468 1,052 1,763 2,630 Depreciation EBITDA 836 1,328 1,559 1,919 Networth 530 1,114 1,825 2,692 Others Depreciation Long Term Debt 2,598 2,380 2,834 2,909 Taxes Paid EBIT 605 1,133 1,337 1,659 Def Tax Liability Change in WC Interest Expense Minority Interest Operating C/F ,118 Other Income Account Payables Capex , PBT ,018 1,304 Other Curr Liabi ,089 1,279 Change in Invest Tax Total Liabilities & Equity 4,285 4,907 6,418 7,678 Others PAT bef. MI & Assoc Net Fixed Assets 2,406 2,561 3,859 4,518 Investing C/F , Minority Interest Capital WIP Change in Debt Profit from Assoc Others Change in Equity Recurring PAT Inventory ,078 1,326 Others Extraordinaires Account Receivables ,157 Financing C/F Reported PAT Other Current Assets Net change in cash FDEPS (Rs) Cash RoE (%) 60 % 75 % 52 % 42 % DPS (Rs) Total Assets 4,285 4,907 6,418 7,678 RoIC (%) 14 % 25 % 24 % 23 % CEPS (Rs) Non-cash Working Capital Core RoIC (%) 12 % 25 % 24 % 23 % FCFPS (Rs) Cash Conv Cycle Div Payout (%) 7 % 6 % 8 % 9 % BVPS (Rs) WC Turnover P/E EBITDAM (%) 26 % 33 % 34 % 34 % FA Turnover P/B PATM (%) 7 % 16 % 17 % 17 % Net D/E P/FCFF Tax Rate (%) 34 % 25 % 24 % 27 % Revenue/Capital Employed EV/EBITDA Sales Growth (%) 42 % 22 % 15 % 23 % Capital Employed/Equity EV/Sales FDEPS Growth (%) 457 % 163 % 25 % 24 % Dividend Yield (%) 0.4 % 0.6 % 1.1 % 1.6 % 2,400 2,000 1,600 1, TTM P/E vs. 2 yr forward EPS growth TTM EV/EBITDA vs. 2 yr forward EBITDA growth TTM P/B vs. 2 yr forward RoE EPS Growth 240% 28x 200% 24x 160% 18x 120% 12x 80% 40% 0% 6x EBITDA Growth 80% 70% 60% 50% 40% 30% 20% 10% 0% 11x 9x 7x 5x 3x 1,800 1,600 1,400 1,200 1, RoE 100% 90% 10x 80% 70% 8x 60% 6x 50% 40% 4x 30% 2x 20% 10% 0% February 14, 2016 Analysts: Umesh Raut umesh.raut@equirus.com ( ) Page 6 of 10

7 Historical Consolidated Financials P&L (Rs Mn) FY12A FY13A FY14A FY15A Balance Sheet (Rs Mn) FY12A FY13A FY14A FY15A Cash Flow (Rs Mn) FY12A FY13A FY14A FY15A Revenue 1,808 2,036 2,306 3,264 Equity Capital PBT Op. Expenditure 1,517 1,686 1,842 2,428 Reserve Depreciation EBITDA Networth Others Depreciation Long Term Debt 2,373 2,519 2,770 2,598 Taxes Paid EBIT Def Tax Liability Change in WC Interest Expense Minority Interest Operating C/F Other Income Account Payables Capex PBT Other Curr Liabi 1,215 1, Change in Invest Tax Total Liabilities & Equity 4,218 4,090 4,264 4,285 Others PAT bef. MI & Assoc Net Fixed Assets 2,949 2,800 2,587 2,406 Investing C/F Minority Interest Capital WIP Change in Debt Profit from Assoc Others Change in Equity Recurring PAT Inventory Others Extraordinaires Account Receivables Financing C/F Reported PAT Other Current Assets Net change in cash EPS (Rs) Cash RoE (%) -82 % -97 % 20 % 60 % DPS (Rs) Total Assets 4,220 4,090 4,265 4,285 RoIC (%) 5 % 7 % -8 % 14 % CEPS (Rs) Non-cash Working Capital Core RoIC (%) 4 % 5 % -8 % 12 % FCFPS (Rs) Cash Conv Cycle Div Payout (%) 0 % 0 % 12 % 7 % BVPS (Rs) WC Turnover P/E EBITDAM (%) 16 % 17 % 20 % 26 % FA Turnover P/B PATM (%) -17 % -9 % 2 % 7 % Net D/E P/FCFF Tax Rate (%) -2 % -9 % 189 % 34 % Revenue/Capital Employed EV/EBITDA Sales growth (%) 8 % 13 % 13 % 42 % Capital Employed/Equity EV/Sales FDEPS growth (%) 44 % -41 % -123 % 457 % Dividend Yield (%) 0.0 % 0.0 % 0.3 % 0.4 % February 14, 2016 Analysts: Umesh Raut umesh.raut@equirus.com ( ) Page 7 of 10

8 Equirus Securities Pankaj Sharma Executive Director /41 Research Analysts Sector/Industry Equity Sales Anirvan Sarkar Banking & Financial Services Vishad Turakhia Ashutosh Tiwari Auto, Metals & Mining Vibhor Rastogi Devam Modi Power & Infrastructure Sweta Sheth DhavalDama FMCG, Mid-Caps Dealing Room Maulik Patel Oil and Gas Ashish Shah Nimish Mehta Pharma IIlesh Savla Umesh Raut Industrials Jigar Chokshi Associates Nirav Prajapati Manoj Gori Sandip Amrutiya Meet Chande Compliance Officer Pranav Mehta Smita Sharma Rahil Shah Raj Kantawala Ram Varun Vikas Jain Rating & Coverage Definitions: Absolute Rating LONG : Over the investment horizon, ATR >= Ke for companies with Free Float market cap > Rs 5 billion and ATR >= 20% for rest of the companies SHORT: ATR <= negative 5% over investment horizon TRADE: Stocks that do not meet the criteria for either LONG or SHORT Relative Rating OVERWEIGHT: Likely to outperform the benchmark by at least 5% over investment horizon BENCHMARK: likely to perform in line with the benchmark UNDERWEIGHT: likely to under-perform the benchmark by at least 5% over investment horizon Target Price and Investment Horizon Target Price is a point value for stocks with Absolute rating of LONG or SHORT and a range value for stocks rated TRADE. Investment Horizon is set at a minimum 3 months to maximum 15 months with target date falling on last day of a calendar quarter. Lite vs. Regular Coverage vs. Spot Coverage We aim to keep our rating and estimates updated at least once a quarter for Regular Coverage stocks. Generally, we would have access to the company and we would maintain detailed financial model for Regular coverage companies. We intend to publish updates on Lite coverage stocks only an opportunistic basis and subject to our ability to contact the management. Our rating and estimates for Lite coverage stocks may not be current. Spot coverage is meant for one-off coverage of a specific company and in such cases, earnings forecast and target price are optional. Spot coverage is meant to stimulate discussion rather than provide a research opinion. Registered Office: Equirus Securities Private Limited Unit No. 1201, 12th Floor, C Wing, Marathon Futurex, N M Joshi Marg, Lower Parel, Mumbai Tel. No: +91 (0) Fax No: +91- (0) Corporate Office: 3rd floor, House No. 9, Magnet Corporate Park, Near Zydus Hospital, B/H Intas Sola Bridge, S.G. Highway Ahmedabad Gujarat Tel. No: +91 (0) Fax No: +91 (0) February 14, 2016 Analysts: Umesh Raut umesh.raut@equirus.com ( ) Page 8 of 10

9 2016 Equirus Securities Private Limited. All rights reserved. For Private Circulation only. This report or any portion hereof may not be reprinted, sold or redistributed without the written consent of Equirus Securities Private Limited Analyst Certification I, Umesh Raut, author to this report, hereby certify that all of the views expressed in this report accurately reflect my personal views about the subject company or companies and its or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Disclaimers Equirus Securities Private Limited (ESPL) having Corporate Identification Number U65993MH2007PTC is registered in India with Securities and Exchange Board of India (SEBI) as a trading member on the Capital Market (Reg. No. INB ), Futures & Options Segment (Reg. No.INF ) of the National Stock Exchange of India Ltd. (NSE) and on Cash Segment (Reg. No.INB ) of Bombay Stock Exchange Limited (BSE).ESPL is also registered with SEBI as Research Analyst under SEBI (Research Analyst) Regulations, 2014 (Reg. No. INH ). There are no disciplinary actions that have been taken by any regulatory authority. ESPL is a subsidiary of Equirus Capital Pvt. Ltd. (ECPL) which is registered with SEBI as Category I Merchant Banker. ESPL/its affiliates provide investment banking services including but not limited to Private Equity, Mergers & Acquisitions, Structured Finance and Institutional Equities. ESPL/its affiliates might have, managed or co-managed public offering of securities of the subject company or have received a mandate from the subject company or might have received compensation from the subject company for investment banking or brokerage services in the past twelve months. ESPL & its affiliates, their directors and employees may from time to time have positions or options in the company and buy or sell the securities of the company (ies) mentioned herein. ESPL or its Analyst did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither ESPL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ESPL has not been engaged in market making activity for the subject company. Research Analyst might have served as an employee of the subject company in the past. This document is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ESPL and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to a certain category of investors. Persons in whose possession this document may come are required to inform themselves of, and to observe, such applicable restrictions. Please delete this document if you are not authorized to view the same. By reading this document you represent and warrant that you have full authority and all rights necessary to view and read this document. This document has been prepared solely for information purpose and does not constitute a solicitation to any person to buy, sell or subscribe a security. ESPL is not soliciting any action based on this report. The information and opinions contained herein is from publicly available data or based on information obtained in good faith from sources believed to be reliable but ESPL provides no guarantee as to its accuracy or completeness. The information contained herein stand on date, which are subject to change or modification. Any such changes could impact our interpretation of relevant information contained herein. While we would endeavour to update the information herein on reasonable basis. ESPL, its affiliates, their directors and employees are under no obligation to update or keep the information current. Also there may be regulatory, compliance, or other reasons that may prevent ESPL and its group companies from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document including the merits and risks involved. This document is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. ESPL and its group companies, employees, directors and agents accept no liability, and disclaim all responsibility, for the consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it. ESPL/its affiliates do and seek to do business with companies covered in its research report. Thus, investors should be aware that the firm may have conflict of interest. Additional Disclaimer for U.S. Persons ESPL/its affiliates are not a registered broker dealer under the U.S. Securities Exchange Act of 1934, as amended (the 1934 act ) and under applicable state laws in the United States. In addition Equirus is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Equirus, including the products and services described herein are not available to or intended for U.S. persons. The information contained in this Report is not intended for any person who is a resident of the United States of America or a resident of any jurisdiction, the laws of which imposes prohibition on soliciting the securities business in that jurisdiction without going through the registration requirements and/or prohibit the use of any information contained in this website. This Report and its respective contents does not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules. February 14, 2016 Analysts: Umesh Raut umesh.raut@equirus.com ( ) Page 9 of 10

10 Disclosures Disclosure of Interest statement for the subject Company Yes/No If Yes, nature of such interest Analyst/ESPL/Associate/Relatives financial interest No Analyst/ESPL/Associate/Relatives actual/beneficial ownership of 1% or more No Analyst/ESPL/Associate/Relatives material conflict of interest No Whether ECPL managed any public offering in past 12 months No February 14, 2016 Analysts: Umesh Raut ( ) Page 10 of 10

Cera Sanitaryware Ltd.

Cera Sanitaryware Ltd. 2016 Equirus All rights reserved Rating Information Price (Rs) 1,980 Target Price (Rs) 2,312 Target Date 30th Jun'17 Target Set On 5th May'16 Implied yrs of growth (DCF) 15 Fair Value (DCF) 2,215 Fair

More information

Cadila Healthcare Ltd.

Cadila Healthcare Ltd. Cadila Healthcare Ltd. Absolute : Short Relative : Underweight Update Note: Estimate ( ), TP ( ), Rating ( ) Regular Coverage -7% ATR in 12 months USFDA raises concern in recently approved Sez facility

More information

Britannia Industries. Change in Estimates: Chg (%) FY17E Chg (%)

Britannia Industries. Change in Estimates: Chg (%) FY17E Chg (%) 2016 Equirus All rights reserved Rating Information Price (Rs) 2,634 Target Price (Rs) 3,546 Target Date 31 st Mar'17 Target Set On 11th Feb'16 Implied yrs of growth (DCF) 20 Fair Value (DCF) 2,292 Fair

More information

Strong sales momentum continues, however margins continue to remain at lower levels. Retain TRADE until clarity on margin improves

Strong sales momentum continues, however margins continue to remain at lower levels. Retain TRADE until clarity on margin improves 2016 Equirus All rights reserved Rating Information Price (Rs) 384 Target Price (Rs) 398 Target Date 30thSept 17 Target Set On 31stJuly'16 Implied yrs of growth (DCF) 20 Fair Value (DCF) 328 Fair Value

More information

Cadila Healthcare Ltd.

Cadila Healthcare Ltd. Cadila Healthcare Ltd. Absolute : Short Relative : Underweight 4QFY16 Results: Estimate (Ø), TP ( ), Rating ( ) Regular Coverage -8% ATR in 14 months Quarter Misses estimates; Muted earnings growth ahead

More information

Reliance Industries Ltd

Reliance Industries Ltd 216 Equirus All rights reserved Rating Information Price (Rs) 1,39 Target Price (Rs) 1,138 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 1,18 Fair Value (DDM) 138 Ind Benchmark

More information

Persistent Systems Ltd.

Persistent Systems Ltd. 2016 Equirus All rights reserved Rating Information Price (Rs) 666 Target Price (Rs) 645 Target Date 30th Sep '17 Target Set On 25th July '16 Implied yrs of growth (DCF) 5 Fair Value (DCF) 644 Fair Value

More information

lower realizations resulted in revenue growth of 9% yoy. Management during the AGM

lower realizations resulted in revenue growth of 9% yoy. Management during the AGM 2016EquirusAll rights reserved Rating Information Price (Rs) 1,922 Target Price (Rs) 2,147 Target Date 31stMar 17 Target Set On 31st July'16 Implied yrs of growth (DCF) 10 Fair Value (DCF) 1,509 Fair Value

More information

Solar Industries India

Solar Industries India Solar Industries India Absolute : ADD Relative : Overweight 4QFY18Result: Estimates(),PT(),Rating() Regular Coverage 9% ATR in 17 Months Strong 4Q led by international business; revise to ADD on earnings

More information

Cipla Ltd. Absolute : ADD Relative : Benchmark. 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 5% ATR in 16 Months

Cipla Ltd. Absolute : ADD Relative : Benchmark. 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 5% ATR in 16 Months 2018EquirusAll rights reserved Rating Information Price (Rs) 520 Target Price (Rs) 547 Target Date 30th Sep'19 Target Set On 22nd May'18 Implied yrs of growth (DCF) 20 Fair Value (DCF) 543 Fair Value (DDM)

More information

eclerx Services Ltd.

eclerx Services Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 1,327 Target Price (Rs) 1,264 Target Date 31st Mar '18 Target Set On 13th Jan '17 Implied yrs of growth (DCF) 5 Fair Value (DCF) 1,174 Fair

More information

P&G Hygiene & Healthcare Ltd.

P&G Hygiene & Healthcare Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 8,015 Target Price (Rs) 8,965 Target Date 30 Jun 18 Target Set On 14 Jun 17 Implied yrs of growth (DCF) 20 Fair Value (DCF) 8,965 Fair Value

More information

Greaves Cotton Ltd. Standalone Estimate Revision:

Greaves Cotton Ltd. Standalone Estimate Revision: Greaves Cotton Ltd. Absolute : REDUCE Relative : UNDERWEIGHT 2QFY18 Result : Estimate (), TP (), Rating () Regular Coverage 2% Upside in 14months Changing industry dynamics to shake up key business verticals

More information

Domestic recovery on track, focus shifts on developing new brands upgrade to LONG on fair valuations Personal Care

Domestic recovery on track, focus shifts on developing new brands upgrade to LONG on fair valuations Personal Care Bajaj Corp Absolute : LONG Relative : Overweight 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 13% ATR in 14 Months Domestic recovery on track, focus shifts on developing new brands

More information

Bajaj Corp. Key risks: Lower than expected volume growth, increase in RM costs.

Bajaj Corp. Key risks: Lower than expected volume growth, increase in RM costs. 2017 Equirus All rights reserved Rating Information Price (Rs) 405 Target Price (Rs) 463 Target Date 30th Sep'18 Target Set On 13th July 17 Implied yrs of growth (DCF) 20 Fair Value (DCF) 388 Fair Value

More information

Manpasand Beverages Ltd.

Manpasand Beverages Ltd. 2015 Equirus All rights reserved Rating Information Primary Issue Size (Rs. Bn) 4.0 Face value (Rs.) 10.0 Issue type 100% Book building Ownership Pre-Issue Post-Issue Promoters 67.2 % 50.4 % Others 32.8

More information

Lupin Ltd. Pharmaceuticals

Lupin Ltd. Pharmaceuticals 2017EquirusAll rights reserved Rating Information Price (Rs) 860 Target Price (Rs) 715 Target Date 31st Dec 18 Target Set On 07th Nov'17 Implied yrs of growth (DCF) 20 Fair Value (DCF) 824 Fair Value (DDM)

More information

DB Corp Equirus All rights reserved Rating Information Price (Rs) 375 Target Price (Rs) 480 Target Date

DB Corp Equirus All rights reserved Rating Information Price (Rs) 375 Target Price (Rs) 480 Target Date DB Corp Absolute : LONG Relative : Overweight 1QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 27% ATR in 14 Months Decent start to FY18, growth to accelerate in second half; retain LONG Media

More information

Graphite India Ltd. Estimate Revision:

Graphite India Ltd. Estimate Revision: Absolute : TRADE Relative : BENCHMARK 4QFY14 Results : Estimate ( ), TP ( ), Rating ( ) Regular Coverage 11% upside in 14 Months Strong free cash flows in FY14 led by 26% reduction in WC days Metals &

More information

Wipro Ltd. Change in estimates: Revised Estimates % Change FY18E FY19E FY18E FY19E

Wipro Ltd. Change in estimates: Revised Estimates % Change FY18E FY19E FY18E FY19E 2017 Equirus All rights reserved Rating Information Price (Rs) 297 Target Price (Rs) 267 Target Date 31st Dec '18 Target Set On 17th Oct '17 Implied yrs of growth (DCF) 5 Fair Value (DCF) 270 Fair Value

More information

Gujarat Gas Ltd. 2QFY18 Results: Estimate ( ), TP ( ), Rating ( ) Volumes in line but margins disappoint on one-offs - downgrade to REDUCE

Gujarat Gas Ltd. 2QFY18 Results: Estimate ( ), TP ( ), Rating ( ) Volumes in line but margins disappoint on one-offs - downgrade to REDUCE Gujarat Gas Ltd. 2QFY18 Results: Estimate ( ), TP ( ), Rating ( ) Volumes in line but margins disappoint on one-offs - downgrade to REDUCE Regular Coverage Absolute: REDUCE Relative: Benchmark 5% Downside

More information

Torrent Power Limited

Torrent Power Limited Absolute : ADD Torrent Power Limited Relative : Overweight 2QFY18 Update: Estimate ( ), TP ( ), Rating ( ) Spot Coverage 7% ATR in 9 months Steady cash generation to continue; higher demand key to swing

More information

Tata Consultancy Services

Tata Consultancy Services 2017 Equirus All rights reserved Rating Information Price (Rs) 2,446 Target Price (Rs) 2,434 Target Date 30th Sep '18 Target Set On 14th July 17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 2,630 Fair

More information

Kajaria Ceramics Ltd.

Kajaria Ceramics Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 676 Target Price (Rs) 714 Target Date 30th Sep'18 Target Set On 21st May'17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 410 Fair Value

More information

Maruti Suzuki India Limited

Maruti Suzuki India Limited Maruti Suzuki India Limited Absolute : LONG Relative : Overweight 4QFY18 Result: Estimate (),PT (), Rating () Regular Coverage 13% ATR in 14 Months Margins impacted by one-offs, to normalize from 1QFY19-

More information

TeamLease Services. Ownership Recent 3M 12M Promoters 40.8 % 0.0 % -2.4 % DII 5.7 % 0.8 % -9.1 % FII 43.9 % 3.6 % 22.8 % Public 9.6 % -4.3 % -11.

TeamLease Services. Ownership Recent 3M 12M Promoters 40.8 % 0.0 % -2.4 % DII 5.7 % 0.8 % -9.1 % FII 43.9 % 3.6 % 22.8 % Public 9.6 % -4.3 % -11. TeamLease Services Absolute: LONG Relative: Overweight 2QFY19 Result: Est. ( ), PT ( ), Rating ( ) Regular Coverage 12% ATR in 17 months One step forward; Upgrade to LONG as valuations turn reasonable

More information

Wipro Ltd. Change in estimates: Revised Estimates % Change FY19E FY20E FY19E FY20E

Wipro Ltd. Change in estimates: Revised Estimates % Change FY19E FY20E FY19E FY20E 2018 Equirus All rights reserved Rating Information Price (Rs) 288 Target Price (Rs) 290 Target Date 31st Mar '19 Target Set On 25th Apr '18 Implied yrs of growth (DCF) 5 Fair Value (DCF) 253 Fair Value

More information

Reliance Industries Ltd

Reliance Industries Ltd 217Equirus All rights reserved Rating Information Price (Rs) 996 Target Price (Rs) 1,45 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 746 Fair Value (DDM) 1,43 Ind Benchmark

More information

Persistent Systems Ltd.

Persistent Systems Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 657 Target Price (Rs) 653 Target Date 30th Sep '18 Target Set On 23rd July 17 Implied yrs of growth (DCF) 5 Fair Value (DCF) 793 Fair Value

More information

Lupin Ltd. Pharmaceuticals

Lupin Ltd. Pharmaceuticals 2018 Equirus All rights reserved Rating Information Price (Rs) 751 Target Price (Rs) 759 Target Date 31st Mar 19 Target Set On 15th May'18 Implied yrs of growth (DCF) 20 Fair Value (DCF) 708 Fair Value

More information

Jagran Prakashan Ltd. 2017EquirusAll rights reserved Rating Information Price (Rs) 173 Target Price (Rs) 200 Target Date

Jagran Prakashan Ltd. 2017EquirusAll rights reserved Rating Information Price (Rs) 173 Target Price (Rs) 200 Target Date Jagran Prakashan Ltd Absolute : LONG Relative : Overweight 3QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 15% ATR in 14 Months Weak quarter but green shoots of recovery emerging - maintain

More information

Sterlite Technologies Ltd.

Sterlite Technologies Ltd. 218 Equirus All rights reserved Rating Information Price (Rs) 336 Target Price (Rs) 41 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 441 Fair Value (DDM) 99 Ind Benchmark Model

More information

Cera Sanitaryware Ltd.

Cera Sanitaryware Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 3,322 Target Price (Rs) 3,538 Target Date 31st Mar'19 Target Set On 06th Nov'17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 2,447 Fair

More information

Kajaria Ceramics Ltd.

Kajaria Ceramics Ltd. Kajaria Ceramics Ltd. Absolute: LONG Relative: Benchmark 2QFY19 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 11% ATR in 17 months 2018 Equirus All rights reserved Rating Information Price

More information

Fiem Industries Limited

Fiem Industries Limited Fiem Industries Limited Absolute: LONG Relative: Overweight 1QFY19 Result: Estimate ( ), PT ( ), Rating ( ) Regular Coverage 85% ATR in 11 Months LED benefit visible in Sales growth, margin should normalize

More information

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,032 Target Price (Rs) 1,116 Target Date

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,032 Target Price (Rs) 1,116 Target Date Minda Industries Absolute : ADD Relative Benchmark 2QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 8% ATR in 14 Months Futuristic product portfolio to drive strong growth maintain ADD Auto

More information

PNC Infratech Limited

PNC Infratech Limited Absolute : LONG PNC Infratech Limited Relative : Overweight 4QFY16 Result: Estimate ( ), Target ( ), Rating ( ) Regular Coverage 26% ATR in 13 Months 2016 Equirus All rights reserved Rating Information

More information

Apex Frozen Foods Ltd

Apex Frozen Foods Ltd Apex Frozen Foods Ltd Absolute : LONG Relative : Overweight 2QFY19 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 53% ATR in 14 Months Valuations attractive even on conservative guidance maintain

More information

Wipro Ltd. Change in estimates:

Wipro Ltd. Change in estimates: 2018EquirusAll rights reserved Rating Information Price (Rs) 307 Target Price (Rs) 329 Target Date 31st Mar '20 Target Set On 24th Oct '18 Implied yrs of growth (DCF) 5 Fair Value (DCF) 298 Fair Value

More information

Gujarat Ambuja Exports

Gujarat Ambuja Exports Gujarat Ambuja Exports Absolute : LONG Relative : Overweight 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 31% ATR in 13 Months Focus shifts to profitable growth maintain LONG Agricultural

More information

Petronet LNG Ltd. Change in Estimates:

Petronet LNG Ltd. Change in Estimates: 217 Equirus All rights reserved Rating Information Price (Rs) 27 Target Price (Rs) Target Date 31st Mar'19 Target Set On 9th Nov'17 Implied yrs of growth (DCF) 2 Fair Value (DCF) Fair Value (DDM) 61 Ind

More information

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,284 Target Price (Rs) 1,449 Target Date

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,284 Target Price (Rs) 1,449 Target Date Minda Industries Absolute : ADD Relative: Overweight 4QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 10% ATR in 16 Months Earnings growth momentum to continue, strong play on premiumization

More information

VIP IndustriesLtd. Change in Estimates: Rs. Mn FY19E Chg (%) FY20E Chg (%) Sales 17,916 4% 21,129 6% EBITDA 2,572-3% 3,109-1% EPS % 14.

VIP IndustriesLtd. Change in Estimates: Rs. Mn FY19E Chg (%) FY20E Chg (%) Sales 17,916 4% 21,129 6% EBITDA 2,572-3% 3,109-1% EPS % 14. VIP IndustriesLtd. Absolute : LONG Relative : BENCHMARK 2QFY19 Result: Estimate(), TP(), Rating() Regular Coverage 17% ATR in 14months Volume growth momentum continues, demand outlook stays robust upgrade

More information

Finolex Industries Ltd.

Finolex Industries Ltd. Finolex Industries Ltd. Absolute: LONG Relative: OVERWEIGHT 2QFY19 Results: Estimates ( ), TP ( ), Rating ( ) Regular Coverage 24% ATR in 17 Months Beat driven by outperformance in PVC resin maintain LONG

More information

Margin disappointment likely quarter-specific; mid/long-term prospects intact retain LONG

Margin disappointment likely quarter-specific; mid/long-term prospects intact retain LONG Finolex Cables Ltd. Absolute : LONG Relative : Overweight 2QFY19 Results: Estimate( ), TP( ),Rating( ) Regular Coverage 18% ATR in 17 months Margin disappointment likely quarter-specific; mid/long-term

More information

Reliance Industries Ltd

Reliance Industries Ltd 217Equirus All rights reserved Rating Information Price (Rs) 1,13 Target Price (Rs) 1,188 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 812 Fair Value (DDM) 221 Ind Benchmark

More information

Century Plyboards India Ltd.

Century Plyboards India Ltd. z 218 Equirus All rights reserved Rating Information Price (Rs) 269 Target Price (Rs) 315 Target Date 3th Sep'19 Target Set On 6th Feb'18 Implied yrs of growth (DCF) 15 Fair Value (DCF) 231 Fair Value

More information

Infosys Ltd. IT Services

Infosys Ltd. IT Services 2019 Equirus All rights reserved Rating Information Price (Rs) 684 Target Price (Rs) 757 Target Date 31st Mar '20 Target Set On 12th Jan '19 Implied yrs of growth (DCF) 20 Fair Value (DCF) 732 Fair Value

More information

Sadbhav Engineering Limited

Sadbhav Engineering Limited Absolute : LONG Sadbhav Engineering Limited Relative : Overweight 4QFY17 Result: Estimate (), Target (), Rating () Regular Coverage 20% ATR in 13 Months 2017 Equirus All rights reserved Rating Information

More information

Avanti Feeds Ltd. Vote for Equirus at Asiamoney Broker Poll'18

Avanti Feeds Ltd. Vote for Equirus at Asiamoney Broker Poll'18 Avanti Feeds Ltd Absolute : LONG Relative : Overweight FY18 Annual report analysis Regular Coverage 65% ATR in 15 Months Near-term headwinds persist, but all priced in retain LONG Consumer Discretionary

More information

PVR Ltd. Media & Entertainment

PVR Ltd. Media & Entertainment PVR Ltd Absolute : LONG Relative : Overweight 2QFY19 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 17% ATR in 17 Months SPI Cinemas to accelerate growth trajectory for PVR maintain LONG Media

More information

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and

More information

Operating metrics stable, marginal uptick in slippages retain ADD

Operating metrics stable, marginal uptick in slippages retain ADD HDFC Bank Absolute :ADD Relative : Equal Weight 1QFY18 Result: Est. ( ), Target ( ), Rating ( ) Regular Coverage 7.6% ATR in 14 months Operating metrics stable, marginal uptick in slippages retain ADD

More information

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E RAMCO S BUY Target Price: Rs 435 Efforts on cost cutting paying off Q2 EBITDA at Rs 2.8 bn (up 30% YoY) was ahead of our estimates due to lower-than-expected costs. Average costs (excluding freight) declined

More information

Cummins India Ltd Bloomberg Code: KKC IN

Cummins India Ltd Bloomberg Code: KKC IN Company Update Margins Under Pressure; Domestic Recovery Underway Half-yearly revenue was flat; margins were under pressure: Cummins India revenue, EBITDA and PAT for H1FY17 reached to Rs.24,784mn, Rs.4,649mn

More information

Symphony Ltd. RESULT UPDATE 31st October 2017

Symphony Ltd. RESULT UPDATE 31st October 2017 . RESULT UPDATE 31st October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 31st October 2017. CMP INR 1,465 Target INR 1,700 Potential

More information

Initiating Coverage. Uflex Ltd.

Initiating Coverage. Uflex Ltd. 2904 Recommendation CMP Target Price BUY Rs. 283 Rs. 444 Better times ahead! reported a good set of numbers for the year FY18 and for Q4. Sales for the quarter increase by 11.8% YoY to Rs 1809.8 Cr and

More information

KDDL (KDDL IN) In expansion mode

KDDL (KDDL IN) In expansion mode INSTITUTIONAL EQUITY RESEARCH KDDL (KDDL IN) In expansion mode INDIA MIDCAP Quarterly Update Top takeaways from 2QFY19 Results in line, recovery in manufacturing & strong growth in precision engineering.

More information

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy 4QFY16 Result Update Institutional Equities Timken India 23 May 2016 Reuters: TMKN.BO; Bloomberg: TIMK IN Margin Expansion Leads To Huge Growth In Profit; Retain Buy Timken India (TIL), the leading manufacturer

More information

Key estimate revision. Financial summary. Year

Key estimate revision. Financial summary. Year : price: EPS: How does our one year outlook change? We retain our positive outlook on WIL and believe that revival in MHCV industry, increasing content per vehicle and opportunity in exports would drive

More information

Jamna Auto Industries

Jamna Auto Industries 2QFY19 Result Update Institutional Equities Jamna Auto Industries Reuters: JMNA.NS; Bloomberg: JMNA IN Performance Below Expectations; Retain Buy Due To Strong Outlook Jamna Auto s 2QFY19 earnings were

More information

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months 2QFY217 Result Update Textile November 16, 216 Garware Wall Ropes Performance Highlights Quarterly Data (`cr) 2QFY17 2QFY16 % yoy 1QFY17 % qoq Revenue 232 214 8.5 225 3.3 EBITDA 4 26 5.9 31 29.4 Margin

More information

P&G Hygiene & Healthcare Ltd.

P&G Hygiene & Healthcare Ltd. 215 Equirus All rights reserved Rating Information Price (Rs) 6,296 Target Price (Rs) 7,29 Target Date 3th Jun'16 Target Set On 24th July'15 Implied yrs of growth (DCF) 2 Fair Value (DCF) 7,29 Fair Value

More information

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 2904 Recommendation CMP Target Price BUY Rs. 312 Rs. 443 Better times ahead! reported a good set of numbers in

More information

Visaka Industries Ltd

Visaka Industries Ltd Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%

More information

Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x

Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x Gujarat Industries Power India Equity Research Power February 10, 2017 Result Update Emkay Your success is our success Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x CMP Target Price

More information

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart 2QFY217 Result Update Auto Ancillary November 8, 216 Amara Raja Batteries Performance Highlights BUY CMP `1,1 Target Price `1,167 Y/E March (` cr) 3QFY16 3QFY15 % chg (yoy) 2QFY16 % chg (qoq) Net Sales

More information

Colgate-Palmolive. Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,063. Recommendation: HOLD

Colgate-Palmolive. Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,063. Recommendation: HOLD Colgate-Palmolive Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin Sector: FMCG CMP: ` 1,063 Recommendation: HOLD Market Statistics Current stock price (`) 1,063 Shares O/S (cr.) 27.2

More information

Key estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9,

Key estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9, : price: EPS: How does our one year outlook change? We retain our positive view on EIM on the back of expected improvement in volume and margin at Royal Enfield (RE) and expected revival in VECV on the

More information

Colgate-Palmolive ACCUMULATE. Performance Highlights. 4QFY2010 Result Update I FMCG

Colgate-Palmolive ACCUMULATE. Performance Highlights. 4QFY2010 Result Update I FMCG 4QFY2010 Result Update I FMCG May 27, 2010 Colgate-Palmolive Performance Highlights ACCUMULATE CMP Target Price Rs715 Rs752 We highlight the fact that the current quarter results are not comparable yoy/qoq,

More information

Colgate Palmolive (CLGT IN) Volume growth revival is the biggest positive

Colgate Palmolive (CLGT IN) Volume growth revival is the biggest positive INSTITUTIONAL EQUITY RESEARCH Colgate Palmolive (CLGT IN) Volume growth revival is the biggest positive INDIA FMCG Quarterly Update Top takeaways from Q2FY19 In line results. Benefits of gross margin improvement

More information

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018 RESULT UPDATE 8 th June, 2018 Sep-15 Jan-16 May-16 Sep-16 Jan-17 May-17 Sep-17 Jan-18 May-18 India Equity Institutional Research II Result Update - Q4FY18 II 8 th June, 2018 2 Under Expansion Mode CMP

More information

Institutional Equities

Institutional Equities 4QFY18 Result Update Institutional Equities Atul Auto 30 May 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Mar Profitability Atul Auto s (AAL) 4QFY18 earnings missed our expectations on account

More information

Havells India. Q4FY17 Result Update Strong Sales growth; Margins stable. Sector: Consumer Durable CMP: ` 515. Recommendation: BUY

Havells India. Q4FY17 Result Update Strong Sales growth; Margins stable. Sector: Consumer Durable CMP: ` 515. Recommendation: BUY Havells India Q4FY17 Result Update Strong Sales growth; Margins stable Sector: Consumer Durable CMP: ` 515 Recommendation: BUY Market statistics Current stock price (`) 515 Shares O/S (cr.) 62.5 Mcap (`

More information

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights JK 20 NOV 2017 Quarterly Update BUY Target Price: Rs 1,220 White cement steals the show JK Cement s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30% YoY) was higher than our and consensus estimates, mainly due

More information

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics 3QFY2017 Result Update Ceramics January 25, 2017 Asian Granito Performance Highlights Quarterly Data (` cr) 3QFY17 3QFY16 % yoy 2QFY17 % qoq Revenue 247 236 4.3 265 (7.1) EBITDA 34 27 25.3 31 7.2 Margin

More information

Fineotex Chemical Ltd

Fineotex Chemical Ltd Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to

More information

Colgate-Palmolive. Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,083. Recommendation: HOLD

Colgate-Palmolive. Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,083. Recommendation: HOLD Colgate-Palmolive Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin Sector: FMCG CMP: ` 1,083 Recommendation: HOLD Market Statistics Current stock price (`) 1,083 Shares O/S (cr.) 27.2

More information

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance 2QFY19 Result Update Gillette India 13 February 2019 Reuters: GILE.NS; Bloomberg: GILL IN Marketing Investments Mask Improved Top-line Performance Gillette India s (GILL) 2QFY19 operating and net earnings

More information

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2, : price: EPS: How does our one year outlook change? We maintain our negative stance on SKF India due to the absence of significant growth momentum drivers over the medium term. While railways could be

More information

Colgate-Palmolive India Ltd.

Colgate-Palmolive India Ltd. RESULT UPDATE 5th February, 2018 Feb-15 Aug-15 Feb-16 Aug-16 Feb-17 Aug-17 Feb-18 India Equity Institutional Research II Result Update - Q3FY18 II 5th February, 2018 CMP INR 1,120 MARKET DATA Target INR

More information

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017 RESULT UPDATE 16 th August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

Result Update. Sterling Tools. Buy

Result Update. Sterling Tools. Buy Sterling Tools Buy Result Update Growth momentum continues Sterling tools (STRT) number were broadly in line with estimates. Margins on a sequential basis have started showing signs of improvement at gross

More information

Emkay. Bonding strongly; Upgrade to BUY. Pidilite Industries. Stellar all-round show

Emkay. Bonding strongly; Upgrade to BUY. Pidilite Industries. Stellar all-round show Pidilite Industries India Equity Research Consumers February 3, 2016 Result Update Emkay Your success is our success Bonding strongly; Upgrade to BUY CMP Rs567 Target Price Rs670 ( ) Rating Upside BUY

More information

PSP Projects Limited SDB Project: A Marvel In The Making!

PSP Projects Limited SDB Project: A Marvel In The Making! S 2018 Equirus All rights reserved PSP Projects Limited SDB Project: A Marvel In The Making! Site Visit We recently visited PSP s Surat Diamond Bourse (SDB) project to get an update on its progress and

More information

TVS Motors. Source: Company Data; PL Research

TVS Motors. Source: Company Data; PL Research Margins trajectory looking up ; Accumulate November 01, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs709

More information

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months 3QFY2017 Result Update FMCG January 30, 2017 ITC Performance Highlights Quarterly result (Standalone) (` cr) 3QFY17 3QFY16 % yoy 2QFY17 %qoq Revenue 9,248 8,867 4.3 9,661 (4.3) EBITDA 3,546 3,475 2.1 3,630

More information

Gillette India. Institutional Equities. 1QFY18 Result Update

Gillette India. Institutional Equities. 1QFY18 Result Update 1QFY18 Result Update Institutional Equities Gillette India 14 November 2017 Reuters: GILE.NS; Bloomberg: GILL IN Robust Growth In Operating Margin Gillette India s or GIL s overall top-line performance

More information

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E. At inflection point Q2FY18 adjusted PAT grew 12% YoY at Rs 27 bn (vs. our estimate Rs 26 bn) in tandem with 17% YoY rise in regulated equity. Core RoE is still healthy at 20.2% though it contracted ~174

More information

Maruti Suzuki. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research Run continues, Royalty reduction positive ; Buy January 29, 2018 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating BUY Price Rs9,277

More information

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation Institutional Equity Research Key data 3 June 28 Sector Capital Goods Market Cap Rs9bn/US$.2bn 52 Wk H/L (Rs) 337/15.5 BSE Avg. daily vol. (6m) 4,437 BSE Code 5373 NSE Code SANGHVIMOV Bloomberg SGM IN

More information

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research Growth/margin bottoming May 25, 2018 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Shreyans Jain shreyansjain@plindia.com +91 22 66322256 Rating BUY Price Rs704 Target Price Rs928 Implied Upside 31.8%

More information

ITC Ltd. RESULT UPDATE 27th October, 2017

ITC Ltd. RESULT UPDATE 27th October, 2017 . RESULT UPDATE 27th October, 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update - II 27th October, 2017 CMP INR 269 Target INR 349 Potential Upside

More information

Nestle India Ltd. RESULT UPDATE

Nestle India Ltd. RESULT UPDATE RESULT UPDATE 15th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update Q1CY17 II 15th May, 2017 CMP INR 6819 Target INR 7075 Potential Upside

More information

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials 1QCY212 Result Update Tyres June 6, 212 Goodyear India Performance Highlights Y/E December (` cr) 1QCY212 1QCY211 % chg (yoy) 4QCY211 % chg (qoq) Net sales 331 336 (1.6) 395 (16.2) EBITDA 2 24 (18.6) 34

More information

Amber Enterprises India Ltd

Amber Enterprises India Ltd 3QFY2019 Result Update Consumer Durable February 16, 2019 Amber Enterprises India Ltd Performance Update (` cr) 3QFY19 3QFY18 % yoy 2QFY19 % qoq Revenue 388.8 338.4 14.9 226.3 71.8 EBITDA 22.1 24.1 (8.2)

More information

Bayer Cropscience (BYRCS IN)

Bayer Cropscience (BYRCS IN) (BYRCS IN) Rating: ACCUMULATE CMP: Rs4,258 TP: Rs4,517 February 4, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating ACCUMULATE

More information

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E Robust quarter with clear growth visibility Dilip Buildcon s (DBL) Q1FY18 sales grew 60% YoY to Rs 16.6 bn, ahead of our estimate of Rs 12.0 bn and consensus of Rs 13.6 bn. EBITDA was up 47% at Rs 3.0

More information

Colgate-Palmolive (India)

Colgate-Palmolive (India) Result Update Colgate-Palmolive (India) 27 July 218 Reuters: COLG.BO; Bloomberg: CLGT IN Tough Times Continue Colgate-Palmolive (India) or CLGT reported a mixed earnings performance in. Volume and revenue

More information

Phillips Carbon Black Ltd

Phillips Carbon Black Ltd 4 Recommendation BUY Snail Pace Recovery CMP (06/02/2013) Rs. 85 Target Price Rs. 110 Sector Stock Details Carbon Black BSE Code 506590 NSE Code Bloomberg Code PHILIPCARB PHCB IN Market Cap (Rs crs) 293

More information